Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 6
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Setmelanotide, a Melanocortin-4 Receptor Agonist, for Obese Patients: A Systematic Review and Meta-Analysis.
Ferraz Barbosa B, Aquino de Moraes FC, Bordignon Barbosa C, Palavicini Santos PTK, Pereira da Silva I, Araujo Alves da Silva B, Cristine Marques Barros J, Rodríguez Burbano RM, Pereira Carneiro Dos Santos N, Rodrigues Fernandes M. Ferraz Barbosa B, et al. Among authors: aquino de moraes fc. J Pers Med. 2023 Oct 4;13(10):1460. doi: 10.3390/jpm13101460. J Pers Med. 2023. PMID: 37888071 Free PMC article. Review.
PD-1/PD-L1 Inhibitors plus Chemotherapy Versus Chemotherapy Alone for Resectable Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Pasqualotto E, Moraes FCA, Chavez MP, Souza MEC, Rodrigues ALSO, Ferreira ROM, Lopes LM, Almeida AM, Fernandes MR, Santos NPCD. Pasqualotto E, et al. Among authors: moraes fca. Cancers (Basel). 2023 Oct 26;15(21):5143. doi: 10.3390/cancers15215143. Cancers (Basel). 2023. PMID: 37958317 Free PMC article. Review.
PD-1/PD-L1 inhibitors plus carboplatin and paclitaxel compared with carboplatin and paclitaxel in primary advanced or recurrent endometrial cancer: a systematic review and meta-analysis of randomized clinical trials.
de Moraes FCA, Pasqualotto E, Lopes LM, Cavalcanti Souza ME, de Oliveira Rodrigues ALS, de Almeida AM, Stecca C, Fernandes MR, Dos Santos NPC. de Moraes FCA, et al. BMC Cancer. 2023 Nov 29;23(1):1166. doi: 10.1186/s12885-023-11654-z. BMC Cancer. 2023. PMID: 38031003 Free PMC article.
Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials.
Moraes FCA, de Oliveira Almeida G, Alves VFC, Priantti JN, Gomes GDC, Carnevalli SVB, Madeira T, Vilbert M, Stecca C, Figueroa Magalhães MC, Fernandes MR, Dos Santos NPC. Moraes FCA, et al. J Pers Med. 2024 Apr 27;14(5):464. doi: 10.3390/jpm14050464. J Pers Med. 2024. PMID: 38793046 Review.
17 results